Is Aclaris Therapeutics, Inc. (ACRS) a Buy, Sell, or Hold?
NASDAQ : ACRS
Aclaris Therapeutics, Inc. — Analyst Ratings
$5.2 USD
-$0.12 (-2.26%)
- Volume
- 1.63M
- Average Volume
- 1.64M
- Market Capitalization
- $726.25M
- P/E Ratio
- -9.29
- Dividend Yield
- 0.00%
- Price Target
- $10.50
- Year High
- $5.88
- Year Low
- $1.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.03
Analyst Consensus Summary
Consensus Rating
Sell
16 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-50.5%
vs Current Price
Price Target
$10.50
Average TargetPrice Target Range
Lowest Target
$10.00
-48.0% DOWNSIDE
Average Target
$10.50
Median Estimate
Highest Target
$12.00
-56.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 16
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 13 | 3 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Biren Amin | $11 | $4.53 | 2026-05-05 06:53 AM | 142.8% |
| Wedbush | Martin Fan | $10 | $4.22 | 2026-04-29 07:44 AM | 137.0% |
| Craig-Hallum | Adam Vogel | $10 | $3.43 | 2026-01-30 07:09 AM | 191.5% |
| BTIG | Julian Harrison | $8 | $3.14 | 2024-11-19 02:35 AM | 154.8% |
| Jefferies | Roger Song | $7 | $3.14 | 2024-11-19 02:34 AM | 122.9% |
| Stifel Nicolaus | Alex Thompson | $3 | $2.275 | 2024-11-06 12:46 PM | 31.9% |